Sfoglia per Autore
Cytokine secretion associated with the clearance of apoptotic bodies in renal cell carcinoma patients
2001 A. Bondanza, P. Rovere, A. Borri, E.R. Caremoli, A. Guidetti, G. Citterio, G. Consogno, V.S. Zimmermann, C. Rugarli, A.A. Manfredi
Clinical protocol. Immunization of patients with malignant melanoma with autologous CD34+ cell-derived dendritic cells transduced ex vivo with a recombinant replication-deficient vaccinia vector encoding the human tyrosinase gene: a phase I trial
2003 M. Di Nicola, C. Carlo-Stella, A. Anichini, R. Mortarini, A. Guidetti, G. Tragni, F. Gallino, M. Del Vecchio, F. Ravagnani, D. Morelli, P. Chaplin, N. Arndtz, G. Sutter, I. Drexler, G. Parmiani, N. Cascinelli, A.M. Gianni
Use of recombinant human growth hormone (rhGH) plus recombinant human granulocyte colony-stimulating factor (rhG-CSF) for the mobilization and collection of CD34+ cells in poor mobilizers
2004 C. Carlo-Stella, M. Di Nicola, R. Milani, A. Guidetti, M. Magni, M. Milanesi, P. Longoni, P. Matteucci, F. Formelli, F. Ravagnani, P. Corradini, A.M. Gianni
Age- and irradiation-associated loss of bone marrow hematopoietic function in mice is reversed by recombinant human growth hormone (rhGH)
2004 C. Carlo-Stella, M. Di Nicola, R. Milani, P. Longoni, M. Milanesi, C. Bifulco, C. Stucchi, A. Guidetti, L. Cleris, F. Formelli, G. Garotta, A.M. Gianni
Mobilization of primitive and committed hematopoietic progenitors in nonhuman primates treated with Defibrotide and recombinant human granulocyte colony-stimulating factor
2004 C. Carlo-Stella, M. Di Nicola, P. Longoni, R. Milani, M. Milanesi, A. Guidetti, K. Haanstra, M. Jonker, L. Cleris, M. Magni, F. Formelli, A.M. Gianni
High response rate and manageable toxicity with an intensive, short-term chemotherapy program for Burkitt’s lymphoma in adults
2004 M. Di Nicola, C. Carlo-Stella, J. Mariotti, L. Devizzi, M. Massimino, A. Cabras, M. Magni, P. Matteucci, A. Guidetti, L. Gandola, A.M. Gianni
Boosting T cell-mediated immunity to tyrosinase by vaccinia virus-transduced, CD34+-derived dendritic cell vaccination: a phase I trial in metastatic melanoma
2004 M. Di Nicola, C. Carlo-Stella, R. Mortarini, P. Baldassari, A. Guidetti, F. Gallino, M. Del Vecchio, F. Ravagnani, M. Magni, P. Chaplin, N. Cascinelli, G. Parmiani, A. Gianni, A. Anichini
IFN-γ enhances the antimyeloma activity of the fully human anti-human leukocyte antigen-DR monoclonal antibody 1D09C3
2006 C. Carlo-Stella, A. Guidetti, M. Di Nicola, C. Lavazza, L. Cleris, P. Longoni, M. Milanesi, M. Magni, Z. Nagy, P. Corradini, A. Carbone, F. Formelli, A.M. Gianni
Rituximab induces effective clearance of minimal residual disease in molecular relapses of mantle cell lymphoma
2006 M. Ladetto, M. Magni, G. Pagliano, F. De Marco, D. Drandi, I. Ricca, M. Astolfi, P. Matteucci, A. Guidetti, B. Mantoan, C.L. Bodoni, M. Zanni, M. Boccadoro, A.M. Gianni, C. Tarella
CD52 antigen expressed by malignant plasma cells can be targeted by alemtuzumab in vivo in NOD/SCID mice
2006 C. Carlo-Stella, A. Guidetti, M. Di Nicola, P. Longoni, L. Cleris, C. Lavazza, M. Milanesi, R. Milani, M. Carrabba, L. Farina, F. Formelli, A.M. Gianni, P. Corradini
Topical prophylaxis of conjunctivitis induced by high-dose cytosine arabinoside
2006 P. Matteucci, C. Carlo-Stella, M. Di Nicola, M. Magni, A. Guidetti, M. Marchesi, A.M. Gianni
Dosimetry in myeloablative (90)Y-labeled ibritumomab tiuxetan therapy : possibility of increasing administered activity on the base of biological effective dose evaluation. Preliminary results.
2007 C. Chiesa, F. Botta, E. Di Betta, A. Coliva, M. Maccauro, G. Aliberti, S. Bavusi, L. Devizzi, A. Guidetti, E. Seregni, A.M. Gianni, E. Bombardieri
Interferon γ enhances the anti-myeloma activity of the fully human anti-HLA-DR monoclonal antibody 1D09C3
2007 C. Carlo-Stella, A. Guidetti, M. Di Nicola, C. Lavazza, L. Cleris, D. Sia, P. Longoni, M. Milanesi, M. Magni, Z. Nagy, P. Corradini, A. Carbone, F. Formelli, A.M. Gianni
High-dose yttrium-90-ibritumomab tiuxetan with tandem stem-cell reinfusion : an outpatient preparative regimen for autologous hematopoietic cell transplantation
2008 L. Devizzi, A. Guidetti, C. Tarella, M. Magni, P. Matteucci, E. Seregni, C. Chiesa, E. Bombardieri, M. Di Nicola, C. Carlo Stella, A. Gianni
Absorbed dose and biologically effective dose in patients with high-risk non-Hodgkin’s lymphoma treated with high-activity myeloablative 90Y-ibritumomab tiuxetan (Zevalin®)
2009 C. Chiesa, F. Botta, A. Coliva, M. Maccauro, L. Devizzi, A. Guidetti, C. Carlo-Stella, E. Seregni, A.M. Gianni, E. Bombardieri
Radioimmunotherapy and secondary leukemia : a case report
2010 M. Magni, M. Di Nicola, A. Testi, A. Cabras, L. Devizzi, A. Guidetti, P. Matteucci, S. Viviani, V. Bonfante, C. Carniti, I. Ricca, A. Carbone, C. Carlo-Stella, A.M. Gianni
Efficacy and safety of high-dose chemotherapy with in vivo purged auto-SCT in relapsed follicular lymphoma : long-term follow-up
2010 M. Magni, M. Di Nicola, C. Carlo Stella, L. Devizzi, A. Guidetti, P. Matteucci, A. Gianni
Myeloablative doses of yttrium-90-ibritumomab tiuxetan and the risk of secondary myelodysplasia/acute myelogenous leukemia
2011 A. Guidetti, C. Carlo Stella, M. Ruella, R. Miceli, L. Devizzi, S.L. Locatelli, A. Giacomini, A. Testi, S. Buttiglieri, A. Risso, L. Mariani, M. Di Nicola, R. Passera, C. Tarella, A. Gianni
Detection of minimal residual disease in hematopoietic progenitor cell harvests : lack of predictive value of peripheral blood and bone marrow analysis in mantle cell and indolent lymphoma
2012 M. Magni, M.D. Nicola, C. Carlo-Stella, P. Matteucci, L. Devizzi, A. Guidetti, F. Ravagnani, A.M. Gianni
Phase II study of sorafenib in patients with relapsed or refractory lymphoma
2012 A. Guidetti, C. Carlo-Stella, S.L. Locatelli, W. Malorni, M. Pierdominici, C. Barbati, R. Mortarini, L. Devizzi, P. Matteucci, A. Marchianò, R. Lanocita, L. Farina, A. Dodero, C. Tarella, M. Di Nicola, P. Corradini, A. Anichini, A.M. Gianni
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile